Literature DB >> 15792042

Maternal phenylketonuria: a case study suggesting the use of prenatal psychotherapy to help control phenylalanine levels.

Kevin M Antshel1, Elizabeth A Gurian, Susan E Waisbren.   

Abstract

Maternal phenylketonuria (MPKU) is an increasingly common concern for health professionals involved in prenatal care. This single-participant study investigated the efficacy of prenatal psychotherapy in improving metabolic control, an important consideration in MPKU pregnancies. Results indicated a robust and positive relationship between psychotherapy and metabolic control. Levels of negative mood and levels of phenylalanine control were also strongly and positively correlated. Implications for treating MPKU are discussed, and prenatal psychotherapy is forwarded as a means of improving birth outcomes in this population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 15792042     DOI: 10.1037/0002-9432.72.4.577

Source DB:  PubMed          Journal:  Am J Orthopsychiatry        ISSN: 0002-9432


  2 in total

1.  The Resource Mothers Study of Maternal Phenylketonuria: preliminary findings.

Authors:  F Rohr; A Munier; D Sullivan; I Bailey; M Gennaccaro; H Levy; H Brereton; S Gleason; B Goss; E Lesperance; K Moseley; R Singh; L Tonyes; H Vespa; S Waisbren
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Preventing maternal phenylketonuria (PKU) syndrome: important factors to achieve good metabolic control throughout pregnancy.

Authors:  Carmen Rohde; Alena Gerlinde Thiele; Christoph Baerwald; Rudolf Georg Ascherl; Dinah Lier; Ulrike Och; Christina Heller; Alexandra Jung; Kathrin Schönherr; Monika Joerg-Streller; Simone Luttat; Sabine Matzgen; Tina Winkler; Stefanie Rosenbaum-Fabian; Oxana Joos; Skadi Beblo
Journal:  Orphanet J Rare Dis       Date:  2021-11-18       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.